Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Editorial

Home HIV testing: Why not in Canada?

CMAJ May 30, 2000 162 (11) 1545;
  • Article
  • Responses
  • Metrics
  • PDF
Loading

FDA-approved home testing for HIV infection has been available in the United States since 1996. Test kits can be purchased anonymously from pharmacies, by mail order or through the Internet. Home testing is really home specimen collection: the patient takes a capillary blood sample at home and mails it to a private laboratory. The result is retrieved a few days later by telephone from trained counsellors who provide information on interpreting the results, seeking follow-up and preventing disease transmission. The cost to obtain results in 3 business days is US$55; in 7 business days, US$44.1

In March 2000, Health Canada finally approved the use of rapid HIV test kits in this country. But it restricts their use to ”the point-of-care by health-care professionals where appropriate HIV counselling is available.”2 Health Canada‚s reasoning is that patients need to be supported through the rapidity of the testing process and to be counselled about the need for confirmatory testing. Few of us would deny the benefits of counselling, but have we also considered the harms? According to clinical practice guidelines, a main component of pretest counselling is ascertainment of risk. Through an exchange more revealing (but less enclosed) than a confession, patients are asked to disclose, among other intimate details of their lives, the last time they had sex with a man and the kinds of sexual activities they engage in.3 People who regard such questions as an invasion of privacy or are ashamed to acknowledge risky behaviour may be deterred from seeking testing.

People who use home testing have a different risk profile than those who use conventional testing. Home testers are more likely to be at risk because of sexual contact with a person who is HIV positive and less likely to be at risk because they are homosexual or use injection drugs.4 A recent national survey in the US revealed that a large proportion of home test kits were purchased by bisexual men and that almost 50% of those who tested positive had never been tested for HIV before.5

The main advantage of home HIV testing is not so much the speed of knowing the results as the fact that it can be conducted in complete privacy. For many years, home pregnancy tests have given women autonomy in obtaining personal health information with the potential to change their lives profoundly. Where the technology exists, why should the public not have the same autonomy and privacy in obtaining other important health information? The public is capable of understanding public health messages about risk factors for HIV. We suspect that most people who are concerned that they may be infected are already aware of the dangers and advantages of testing. The public does not need Health Canada‚s protection or its support for elaborated disclosure. Home testing should be made available in Canada and its use promoted. More HIV infections will be detected earlier, treatments will be started sooner and, we may hope, some potential transmissions will be prevented. — CMAJ

References

  1. 1.↵
    See Home Access Health Corporation Web site: www.homeaccess.com
  2. 2.↵
    Point-of-care HIV testing using simple/rapid HIV test kits: guidance for health care professionals. Can Commun Dis Rep 2000;26(7):49-59. Available: www.hc-sc.gc.ca/hpb/lcdc/publicat /ccdr/00vol26/dr2607ea.html
    OpenUrlPubMed
  3. 3.↵
    Counselling guidelines for HIV testing. 3. Components of pretest counselling. Ottawa: Canadian Medical Association; 1995. Available: www.cma .ca/cpgs/hiv/3pretest.htm
  4. 4.↵
    McQuitty M, McFarland W, Kellogg TA, White E, Katz MH. Home collection versus publicly funded HIV testing in San Francisco: Who tests where? J Acquir Immune Defic Syndr 1999;21:417-22.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Branson BM. Home sample collection tests for HIV infection. JAMA 1998;280:1699-701.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

CMAJ
Vol. 162, Issue 11
30 May 2000
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Home HIV testing: Why not in Canada?
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Home HIV testing: Why not in Canada?
CMAJ May 2000, 162 (11) 1545;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Home HIV testing: Why not in Canada?
CMAJ May 2000, 162 (11) 1545;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • HIV testing and informed consent
  • A step toward putting a genie back in its bottle
  • Google Scholar

More in this TOC Section

  • “Less is better” is the best message when talking to patients about alcohol
  • Nouvelle politique sur l’utilisation des outils d’intelligence artificielle dans les manuscrits soumis au JAMC
  • Without more acute care beds, hospitals are on their own to grapple with emergency department crises
Show more Editorial

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire